Monotherapy with Amikacin or Piperacillin-Tazobactum Empirically in Neonates at Risk for Early-Onset Sepsis: A Randomized Controlled Trial

Conclusions: Monotherapy with amikacin as an empirical antibiotic did not result in a higher incidence of treatment failure in neonates at risk for early-onset sepsis as compared with piperacillin-tazobactum. Both antibiotics were effective in management of babies with early-onset sepsis.
Source: Journal of Tropical Pediatrics - Category: Tropical Medicine Authors: Tags: Original Papers Source Type: research